Lot and NDC info
| 01 | Inspected 74% of remaining pouches. |
| 02 | Magnesium dose: 4g/100mL. |
| 03 | For preeclampsia/eclampsia seizure prevention. |
| 04 | TXA for hemophilia hemorrhage reduction. |
| 05 | Low likelihood of patient exposure. |
| 06 | FDA MedWatch for reporting. |
What is lot number of recall?
The specific lot recalled is AH250162, distributed between December 22, 2025, and February 27, 2026, to wholesalers and distributors nationwide.
Who should return the product?
Hospitals that received the recalled Magnesium Sulfate lot should stop using it and return it to Amneal Pharmaceuticals at 21 Colonial Drive, Piscataway, NJ 08854.
How to contact Amneal about recall?
Contact Amneal at 833-582-0812 (Mon-Fri 8am-5pm EST), fax 631-983-2595, or email MagnesiumSulfateRecall@amneal.com for questions.
What is preeclampsia?
Preeclampsia is a pregnancy complication characterized by high blood pressure and potential organ damage, where magnesium sulfate is used to prevent and control seizures.
What does eclampsia involve?
Eclampsia is a severe progression of preeclampsia involving seizures in pregnant individuals, treated preventively with magnesium sulfate to avoid life-threatening outcomes.